MxA has been used as a reliable marker to detect type I IFN in clinical settings, including SLE and hepatitis C infection [37], [38], as it is exclusively expressed after engagement of type I IFNs to its receptor [9]. Here, MX1 is linked to systemic lupus erythematosus.